VIDEO: Healio prepares for Women in Medicine Summit

This year’s Women in Medicine Summit will be held virtually on Oct. 9-10. The conference will address disparities in compensation, promotion and other career advancement opportunities among women in health care.In this video, Shikha Jain, MD, FACP, chair and founder of the summit, discusses her goals for the meeting and how it can create opportunities…

Nobel Prize in Medicine awarded to trio of scientists for discovery of hepatitis C virus

The Nobel Prize in Medicine was awarded to Harvey J. Alter, MD, Michael Houghton, PhD, DSc Hon and Charles M. RicePhD at the Karolinska Institutet in Sweden for the discovery of the hepatitis C virus.According to the release from the Nobel Assembly, the three scientists “made seminal discoveries that led to the identification of a…

Leaders in GI need to be ‘part of the solution not the problem’

Leadership poses challenges for gastroenterologists in the health care landscape that is always evolving and consolidating.In his presentation for the American Society for Gastrointestinal Endoscopy’s virtual GI Outlook conference, Charles M. Nunn, Jr., MD, CPE, MMM, FACPE, from Lynchburg, Virginia, offered six pearls for GIs on how to be the best leader at their practice…

Study shows disparities in access to molecular diagnostics for colorectal cancer

Although testing for microsatellite instability and mismatch repair deficiency has increased for advanced colorectal cancer, substantial gaps in testing remain among certain patient groups, according to study results.The results, presented at American Association for Cancer Research Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, showed testing occurred less…

Ustekinumab may trigger severe cardiovascular events in high-risk individuals

Treatment of psoriatic conditions or Crohn’s disease with ustekinumab was associated with severe cardiovascular events in certain high-risk patients, according to a study.Florence Poizeau, MD, and colleagues aimed to assess whether initiation of the interleukin-12/23p40 antibody ustekinumab would lead to severe cardiovascular events in patients with moderate to severe psoriasis, psoriatic arthritis and Crohn’s disease.The…